RAFFA WEALTH MANAGEMENT, LLC’s United Therapeutics UTHR Stock Holding History

RAFFA WEALTH MANAGEMENT, LLC’s Portfolio UTHR Stock Details UTHR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.08K	Buy	2 +1	+100%	+$563	﹤0.01%	995
2026 Q1	$593	Buy	+1	New	+$498	﹤0.01%	1046
2022 Q3	–	Sell	-2	Closed	-$471	–	1202
2022 Q2	$471	Hold	2	–	–	﹤0.01%	1030
2022 Q1	$359	Buy	+2	New	+$381	﹤0.01%	1087
2021 Q4	–	Sell	-1	Closed	-$185	–	1148
2021 Q3	$185	Hold	1	–	–	﹤0.01%	1107
2021 Q2	$179	Sell	1 -3	-75%	-$571	﹤0.01%	1084
2021 Q1	$669	Buy	+4	New	+$667	﹤0.01%	978
2016 Q3	–	Sell	-6	Closed	-$636	–	886
2016 Q2	$636	Hold	6	–	–	﹤0.01%	579
2016 Q1	$669	Hold	6	–	–	﹤0.01%	550
2015 Q4	$940	Hold	6	–	–	﹤0.01%	407
2015 Q3	$787	Hold	6	–	–	﹤0.01%	458
2015 Q2	$1.04K	Hold	6	–	–	﹤0.01%	379
2015 Q1	$1.03K	Buy	+6	New	+$915	﹤0.01%	382
2014 Q2	–	Sell	-13	Closed	-$1.22K	–	285
2014 Q1	$1.22K	Buy	+13	New	+$1.33K	﹤0.01%	236

Other funds holding UTHR

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Retirement Systems of Alabama Montgomery, Alabama $33.2B AUM 38.15% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Atwood & Palmer Kansas City, Missouri $1.87B AUM 24.22% 1-Year Est. Return

PCM

Polaris Capital Management Boston, Massachusetts $1.06B AUM 40.82% 1-Year Est. Return

SAM

Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

AIM

Achmea Investment Management Zeist, Netherlands $4B AUM 31.99% 1-Year Est. Return

AAP

Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return

RAFFA WEALTH MANAGEMENT, LLC's UTHR Position: Q2 2026 in Review

RAFFA WEALTH MANAGEMENT, LLC increased its United Therapeutics (UTHR) stake by 100% in Q2 2026, buying an estimated $563 and bringing the position to 2 shares worth $1.08K. The position accounts for ﹤0.01% of the portfolio, ranked #995.

RAFFA WEALTH MANAGEMENT, LLC first reported a position in UTHR in Q1 2014 and has held it in 14 quarters since. The position peaked at $1.22K in Q1 2014. 219 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

RAFFA WEALTH MANAGEMENT, LLC held 2 shares of United Therapeutics worth $1.08K as of Q2 2026.
RAFFA WEALTH MANAGEMENT, LLC bought 1 United Therapeutics share in Q2 2026, an estimated $563.
United Therapeutics made up ﹤0.01% of RAFFA WEALTH MANAGEMENT, LLC's portfolio in Q2 2026, its #995 holding.
RAFFA WEALTH MANAGEMENT, LLC first reported a position in United Therapeutics in Q1 2014 and has held it in 14 quarters since.
RAFFA WEALTH MANAGEMENT, LLC's United Therapeutics position peaked at $1.22K in Q1 2014.
219 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on RAFFA WEALTH MANAGEMENT, LLC's 13F filing for Q2 2026, filed 27 Jul 2026.